Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Eli Lilly, Shionogi to Codevelop, Comarket Duloxetine in Japan
February 19, 2007
- Japan, EU Reach Agreement on Confidentiality of Drug Information
February 19, 2007
- Chugai: Sales, Profits Impacted by NHI Price Cuts
February 19, 2007
- REGULATORY NEWS IN BRIEF
February 19, 2007
- Companies Gearing Up for Pollinosis Season
February 19, 2007
- Sawai's New 3-Year Plan to Focus on New Formulations, Data Supply
February 19, 2007
- BUSINESS NEWS IN BRIEF
February 19, 2007
- Nihon Chouzai: Profits Hit By GE Drug Promotion Costs
February 19, 2007
- About 17% of Prescriptions Permit GE Substitution: Survey
February 19, 2007
- Sawai, Nichi-Iko Top GE Drug Suppliers to Hospitals: Survey
February 19, 2007
- MEDICAL DEVICE NEWS IN BRIEF
February 19, 2007
- Nippon Shinyaku to Commercialize RNA Drug Discovery Technology
February 19, 2007
- TS-1 Adjuvant Therapy Reduces Mortality in Gastric Cancer
February 19, 2007
- MCH Group's ZoeGene Corp. to Be Reorganized
February 19, 2007
- New GL for Stomach Cancer Screening Expected by March
February 19, 2007
- Tohoku Univ. Researchers Develop New Endoscopic Laser Treatment System
February 12, 2007
- Olympus Applies for Swallowable Imaging Capsule
February 12, 2007
- PREMINENT Opens Door to Combination Drugs
February 12, 2007
- Olympus Launches World's First AFT Videoscopes
February 12, 2007
- GENERIC NEWS IN BRIEF
February 12, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…